stella
beta
Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma — Stella
Recruiting
Back to Peripheral T Cell Lymphoma trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Trial locations
(1 site)
China
The First Affiliated Hosptial of Xiamen University, Xiamen, Fujian
View full record on ClinicalTrials.gov